Short-term tools to measure responsiveness to growth hormone replacement

Hormone Research

Volumn 55, Issue SUPPL. 2, 2001, Pages 40-43

  Jørgensen, Jens O L ^a   Hansen, Troels K ^a   Conceição, Flávia Lucia ^a   Christensen, Jens J ^a   Vahl, Nina ^a   Christiansen, Jens Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Growth hormone; Growth hormone therapy; Insulin like growth factor I; Insulin like growth factor I generation test; Responsiveness to GH; Techniques

Indexed keywords

BIOLOGICAL MARKER; GROWTH HORMONE; SOMATOMEDIN C;

ANALYTIC METHOD; BODY COMPOSITION; BODY HEIGHT; CONFERENCE PAPER; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FITNESS; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE RESPONSE; HORMONE SENSITIVITY; HORMONE SUBSTITUTION; HUMAN; HYDRATION; LIPOLYSIS; LONG TERM CARE; METABOLIC BALANCE; OUTCOMES RESEARCH; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELIABILITY; SAFETY; SHORT STATURE; SIDE EFFECT; TREATMENT OUTCOME;

ENDOCRINOLOGY; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 18444382696     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063473     Document Type: Conference Paper

References (15)

1. Sulfation factor measurements as an aid in the recognition of pituitary dwarfism
2. Studies with human growth hormone. An attempt to correlate metabolic response during short-term administration with linear growth during prolonged therapy
3. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay
4. Induction of immunoreactive somatomedin C in human serum by growth hormone: Dose-response relationship and effect on chromatographic profiles
5. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone
6. Children with normal-variant short stature: Treatment with human growth hormone for six months
7. Growth hormone treatment in short children: Relationship between growth and serum insulin-like growth factor I and II levels
8. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients
9. Growth hormone dose regimens in adult GH deficiency: Effects on biochemical growth markers and metabolic parameters
10. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers
11. Decreased plasma and extracellular volume in growth hormone-deficient adults and the acute and prolonged effects of GH administration: A controlled experimental study
12. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis
13. Effect of growth hormone on plasma fatty acids
14. Dose-response studies on the metabolic effects of a growth hormone pulse in humans
15. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: Relation to age, sex, and body composition